Difference between revisions of "Part:BBa K4585008"
Line 38: Line 38:
 
             <h2 class="pageContent-main__title pageContent-main__subtitle">
 
             <h2 class="pageContent-main__title pageContent-main__subtitle">
 
                 <!--class="pageContent-main__title" means it is the sub title-->
 
                 <!--class="pageContent-main__title" means it is the sub title-->
−
                2 Experiment
+
2 Experiment
−
       
+
            </h2>
−
          </h2>
+
             <h2 class="pageContent-main__title pageContent-main__subtitle">
−
             <div class="pageContent-main__textBox">
+
                 <!--class="pageContent-main__title" means it is the sub title-->
−
                 <!--all the content must included in this div-->
+
 
                 2.1 Method
 
                 2.1 Method
 
             </h2>
 
             </h2>
Line 71: Line 70:
 
             <div class="pageContent-main__textBox">
 
             <div class="pageContent-main__textBox">
 
                 <!--all the content must included in this div-->
 
                 <!--all the content must included in this div-->
−
                 <p>The two ends of the pGL4.35-3×HA-9×GAL4UAS-KRAB-NLS linearized vectror need to be complementary to the two ends of the corresponding recombinant fragments to ensure the success of homologous recombination ligation.
+
                 <p>After sequencing and ensuring the sequence was correct, we applied it to the experiments. Store at 4℃.
 
                 </p>
 
                 </p>
−
   
+
            </div>
 
        
 
        
 
</body>
 
</body>
 
</html>
 
</html>

Revision as of 16:04, 8 October 2023


pGL4.35-3xHA-9xGAL4UAS-KRAB-NLS linearized vector

The objective was to synthesize the pGL4.35-3 HA-9 GAL4UAS-KRAB-NLS plasmid by homologous recombination with the KRAB homologous recombination fragment .

pGL4.35-3×HA-9×GAL4UAS-KRAB-NLS linearized vector

We based on the sequence of the pGL4.35 plasmid. Through homologous recombination experiments, the Gal 4 sequence, 3× HA sequence were ligated to the pGL4.35 plasmid, and nine UAS sequences were inserted simultaneously. Special primers were designed, and then the plasmid was cut into linear sequences of a length of about 4500 bp by PCR. The two ends of the linear sequence can be complementary to both ends of the KRAB homologous recombination fragment, and the purpose is to perform homologous recombination with the KRAB homologous recombination fragment to obtain the target product pGL4.35-3×HA-9×GAL4UAS-KRAB-NLS plasmid.

1 Pattern Diagram


Fig.1 The agarose gel electrophoresis of pGL4.35-3×HA-9×GAL4UAS-KRAB-NLS linearized vector

2 Experiment

2.1 Method

The pGL4.35-3×HA-9×GAL4UAS-KRAB-NLS plasmid could express GAL4-KRAB, and GAL4-KRAB could bind 9×UAS and inhibit downstream gene expression, therefore GAL4-KRAB could inhibit GnRH expression. Considering that the plasmid itself contains a 9×UAS sequence, GAL4-KRAB can also suppress its own expression.

2.2 Results

HEK 293T cells were transiently transfected with GAL-VP64 and GAL-KRAB plasmids, and an appropriate amount of Luciferase plasmids were transfected to simulate GnRH. The experiment showed that the GAL-VP64 plasmid could initiate the expression of GAL4-KRAB and Luciferase.


Fig 2. Bioluminescence intensity when GAL4-VP64=GAL4-KRAB=400 ng

3.Caution

After sequencing and ensuring the sequence was correct, we applied it to the experiments. Store at 4℃.